All News #Library
Others
Vergent Shows Abenacianine Boosts Tumor Visibility in Surgery
22 May 2025 //
BUSINESSWIRE
Vergent Initiates Phase 2 Study Evaluating VGT-309
13 Dec 2023 //
BUSINESSWIRE
Vergent Bioscience shares Phase IIb plans for oncology imaging agent
03 Nov 2022 //
CLINICALTRIALSARENA

Market Place
Sourcing Support